Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b.
Matsumoto N, Ikeda H, Shigefuku R, Hattori N, Watanabe T, Matsunaga K, Hiraishi T, Tamura T, Noguchi Y, Fukuda Y, Ishii T, Okuse C, Sato A, Suzuki M, Itoh F. Matsumoto N, et al. Among authors: suzuki m. PLoS One. 2016 Mar 18;11(3):e0151238. doi: 10.1371/journal.pone.0151238. eCollection 2016. PLoS One. 2016. PMID: 26990758 Free PMC article.
Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?
Ikeda H, Okuse C, Watanabe T, Matsumoto N, Matsunaga K, Shigefuku R, Hattori N, Hiraishi T, Fukuda Y, Noguchi Y, Ishii T, Shima J, Nakahara K, Yamamoto H, Yasuda H, Yotsuyanagi H, Koike K, Itoh F, Suzuki M. Ikeda H, et al. Among authors: suzuki m. Turk J Gastroenterol. 2016 Mar;27(2):165-72. doi: 10.5152/tjg.2016.150300. Turk J Gastroenterol. 2016. PMID: 27015621 Free article.
Impact of resistance-associated variant dominancy on treatment in patients with HCV genotype 1b receiving daclatasvir/asunaprevir.
Ikeda H, Watanabe T, Okuse C, Matsumoto N, Ishii T, Yamada N, Shigefuku R, Hattori N, Matsunaga K, Nakano H, Hiraishi T, Kobayashi M, Yasuda K, Yamamoto H, Yasuda H, Kurosaki M, Izumi N, Yotsuyanagi H, Suzuki M, Itoh F. Ikeda H, et al. Among authors: suzuki m. J Med Virol. 2017 Jan;89(1):99-105. doi: 10.1002/jmv.24608. Epub 2016 Jul 6. J Med Virol. 2017. PMID: 27329864
Daclatasvir and asunaprevir improves health-related quality of life in Japanese patients infected with hepatitis C virus.
Ikeda H, Watanabe T, Matsumoto N, Hiraishi T, Nakano H, Noguchi Y, Hattori N, Shigefuku R, Yamashita M, Nakahara K, Matsunaga K, Okuse C, Yotsuyanagi H, Tanaka A, Suzuki M, Itoh F. Ikeda H, et al. Among authors: suzuki m. JGH Open. 2018 May 14;2(3):87-92. doi: 10.1002/jgh3.12052. eCollection 2018 Jun. JGH Open. 2018. PMID: 30483569 Free PMC article.
Pancreatic involvement in chronic viral hepatitis.
Katakura Y, Yotsuyanagi H, Hashizume K, Okuse C, Okuse N, Nishikawa K, Suzuki M, Iino S, Itoh F. Katakura Y, et al. Among authors: suzuki m. World J Gastroenterol. 2005 Jun 21;11(23):3508-13. doi: 10.3748/wjg.v11.i23.3508. World J Gastroenterol. 2005. PMID: 15962364 Free PMC article.
Short-term prolongation of pegylated interferon and ribavirin therapy for genotype 1b chronic hepatitis C patients with early viral response.
Ikeda H, Suzuki M, Okuse C, Yamada N, Okamoto M, Kobayashi M, Nagase Y, Takahashi H, Matsunaga K, Matsumoto N, Itoh F, Yotsuyanagi H, Koitabashi Y, Yasuda K, Iino S. Ikeda H, et al. Among authors: suzuki m. Hepatol Res. 2009 Aug;39(8):753-9. doi: 10.1111/j.1872-034X.2009.00523.x. Epub 2009 May 7. Hepatol Res. 2009. PMID: 19467024
Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B.
Okuse C, Yotsuyanagi H, Yamada N, Okamoto M, Ikeda H, Kobayashi M, Fukuda Y, Takahashi H, Nagase Y, Suzuki Y, Matsunaga K, Ishii T, Matsumoto N, Koike K, Suzuki M, Itoh F. Okuse C, et al. Among authors: suzuki y, suzuki m. Hepatol Res. 2010 May;40(5):461-9. doi: 10.1111/j.1872-034X.2010.00639.x. Epub 2010 Apr 14. Hepatol Res. 2010. PMID: 20412327
15,159 results
You have reached the last available page of results. Please see the User Guide for more information.